Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. More Details
Flawless balance sheet with weak fundamentals.
Share Price & News
How has Proteomics International Laboratories's share price performed over time and what events caused price changes?
Latest Share Price and Events
7 Day Return
AU Life Sciences
1 Year Return
AU Life Sciences
Long-Term Price Volatility Vs. Market
How volatile is Proteomics International Laboratories's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 hours ago | Simply Wall StIf You Had Bought Proteomics International Laboratories (ASX:PIQ) Shares Five Years Ago You'd Have Earned 396% Returns
1 month ago | Simply Wall StWe're Not Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn
5 months ago | Simply Wall StWhy Proteomics International Laboratories' (ASX:PIQ) CEO Pay Matters
Is Proteomics International Laboratories undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Price To Earnings Ratio
Price to Earnings Growth Ratio
Price to Book Ratio
How is Proteomics International Laboratories forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings per Share Growth Forecasts
Future Return on Equity
How has Proteomics International Laboratories performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Return on Equity
How is Proteomics International Laboratories's financial position?
Financial Position Analysis
Debt to Equity History and Analysis
What is Proteomics International Laboratories's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Stability and Growth of Payments
Current Payout to Shareholders
Future Payout to Shareholders
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dr. Richard John Lipscombe, Ph.D (London), MA (Oxford), co-founded Proteomics International Laboratories Limited in 2001 and serves as its Managing Director and Director since June 09, 2014. Mr. Lipscombe ...
CEO Compensation Analysis
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Proteomics International Laboratories Limited's company bio, employee growth, exchange listings and data sources
- Name: Proteomics International Laboratories Limited
- Ticker: PIQ
- Exchange: ASX
- Founded: 2001
- Industry: Life Sciences Tools and Services
- Sector: Pharmaceuticals & Biotech
- Market Cap: AU$125.195m
- Shares outstanding: 105.21m
- Website: https://www.proteomics.com.au
- Proteomics International Laboratories Limited
- QEII Medical Centre
- QQ Block
- Western Australia
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and dev...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/07/26 17:26|
|End of Day Share Price||2021/07/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.